Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCG pretreatment in poor ovarian responders
PACTR201602001448165Not yet recruiting
- Sponsor
- Cambridge University Hospitals
- Start
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of human chorionic gonadotropin in female infertility and poor ovarian response (POR) (2 arms), sponsored by Cambridge University Hospitals. Primary endpoint: clinical pregnancy rate. Planned start Mar 2016; status: not yet recruiting.
02
Drugs
human chorionic gonadotropin
03
Conditions
female infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on PACTR201602001448165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201602001448165.